Dyne Therapeutics, Inc. (DYN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$14.96
Day's range
$18.21

Dyne Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 30.91 M $686.56 M   0.41% 18.73%
BLACKROCK, INC. 08/07/2026 12.40 M $275.50 M   6.02% 7.52%
JUPITER TOPCO LLC 08/14/2026 12.00 M $266.63 M   100.00% 7.27%
FMR LLC 08/13/2026 11.21 M $248.91 M   25.79% 6.79%
STATE STREET CORP 08/07/2026 7.46 M $165.65 M   12.09% 4.52%
ORBIS ALLAN GRAY LTD 08/14/2026 7.01 M $155.62 M   3.61% 4.25%
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 08/13/2026 6.80 M $151.03 M   -25.52% 4.12%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 6.31 M $140.17 M   -1.47% 3.82%
TCG CROSSOVER MANAGEMENT, LLC 08/14/2026 4.62 M $102.50 M   0.00% 2.80%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 4.05 M $89.92 M   -2.73% 2.45%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 3.94 M $87.44 M   69.08% 2.39%
FCPM III SERVICES B.V. 08/14/2026 3.85 M $85.47 M   -17.14% 2.33%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 3.74 M $83.16 M   6.83% 2.27%
VESTAL POINT CAPITAL, LP 08/14/2026 3.38 M $74.96 M   -15.63% 2.05%
ORBIMED ADVISORS LLC 08/14/2026 3.24 M $71.86 M   10.89% 1.96%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 08/14/2026 3.15 M $70.03 M   0.00% 1.91%
JPMORGAN CHASE & CO 08/12/2026 3.15 M $67.15 M   -3.13% 1.91%
ARMISTICE CAPITAL, LLC 08/14/2026 3.09 M $68.57 M   -2.77% 1.87%
PERCEPTIVE ADVISORS LLC 08/14/2026 2.69 M $59.73 M   -42.40% 1.63%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 2.55 M $56.64 M   82.14% 1.55%
BANK OF AMERICA CORP /DE/ 08/14/2026 2.23 M $49.60 M   54.74% 1.35%
VR ADVISER, LLC 08/14/2026 2.17 M $48.28 M   0.00% 1.32%
GOLDMAN SACHS GROUP INC 08/14/2026 2.16 M $47.91 M   25.19% 1.31%
SIREN, L.L.C. 08/13/2026 2.13 M $47.29 M   -4.49% 1.29%
FRANKLIN RESOURCES INC 08/13/2026 2.03 M $45.10 M   1.08% 1.23%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 1.95 M $43.22 M   104.55% 1.18%
BIOIMPACT CAPITAL LLC 08/14/2026 1.92 M $42.69 M   36.50% 1.16%
SAMLYN CAPITAL, LLC 08/14/2026 1.75 M $38.97 M   -8.73% 1.06%
SOFINNOVA INVESTMENTS, INC. 08/14/2026 1.66 M $36.83 M   1.50% 1.00%
PALO ALTO INVESTORS LP 08/19/2026 1.65 M $36.59 M   -0.33% 1.00%
VIVO CAPITAL, LLC 08/14/2026 1.56 M $34.59 M   0.00% 0.94%
ABRDN PLC 07/31/2026 1.54 M $34.19 M   7.62% 0.93%
DEEP TRACK CAPITAL, LP 08/14/2026 1.50 M $33.32 M   -25.00% 0.91%
MARSHALL WACE, LLP 08/13/2026 1.49 M $33.07 M   1,690.70% 0.90%
POLAR CAPITAL HOLDINGS PLC 08/14/2026 1.29 M $28.58 M   -5.32% 0.78%
NORTHERN TRUST CORP 08/13/2026 1.28 M $28.39 M   6.61% 0.77%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 1.20 M $26.70 M   3.78% 0.73%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 1.20 M $26.70 M   100.00% 0.73%
CITADEL ADVISORS LLC 08/14/2026 1.14 M $25.41 M   468.73% 0.69%
SATURN V CAPITAL MANAGEMENT LLC 08/14/2026 1.06 M $23.49 M   9.40% 0.64%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 988.95 K $21.96 M   4.38% 0.60%
NOVO HOLDINGS A/S 08/14/2026 960.39 K $21.33 M   100.00% 0.58%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 942.15 K $20.93 M   -3.09% 0.57%
BRAIDWELL LP 08/14/2026 921.60 K $20.47 M   -45.21% 0.56%
FRONTIER CAPITAL MANAGEMENT CO LLC 08/14/2026 874.14 K $19.41 M   6.36% 0.53%
BAKER BROS. ADVISORS LP 08/14/2026 813.45 K $18.07 M   0.00% 0.49%
FIERA CAPITAL CORP 08/07/2026 789.99 K $17.55 M   -42.78% 0.48%
MORGAN STANLEY 08/13/2026 746.20 K $16.57 M   -19.68% 0.45%
ARTISAN PARTNERS LIMITED PARTNERSHIP 08/13/2026 659.79 K $14.65 M   6.51% 0.40%
RAYMOND JAMES FINANCIAL INC 08/14/2026 576.35 K $12.80 M   27.61% 0.35%

Dyne Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 314 institutional investors and hedge funds held shares of Dyne Therapeutics Inc. The most heavily invested institutionals were:

T. Rowe Price Investment Management, Inc.: 30.91 M

BlackRock, Inc.: 12.4 M

Jupiter Topco LLC: 12 M

FMR LLC: 11.21 M

STATE STREET CORP: 7.46 M

Orbis Allan Gray Ltd: 7.01 M

116.14% of Dyne Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 226.22 M shares in the last 24 months. This purchase volume represents approximately $4.00 B in transactions.